Results 181 to 190 of about 16,052,874 (333)
Parameter Estimation of Weibull Distribution Based on Second-Kind Statistics
The log-cumulant estimator is proposed to estimate the parameters of Weibull distribution based on second-kind statistics. With the explicit closed form expressions, the log-cumulant estimator is computationally efficient.
Zengguo Sun, Chongzhao Han
doaj
The Impacts of Cash and In-Kind Transfers on Consumption and Labor Supply: Experimental Evidence from Rural Mexico [PDF]
The authors use the unique experimental design of the Food Support Program (Programa Apoyo Alimentario) to analyze in-kind and cash transfers in the poor rural areas of southern states of Mexico.
Gonzalez-Cossio, Teresa +1 more
core
Intratumour heterogeneity complicates precision management of advanced endometrial cancer. Circulating tumor DNA (ctDNA) offers a minimally invasive strategy to capture tumor evolution and therapeutic resistance. Here, we compare tumor‐agnostic NGS with tumor‐informed ddPCR, outlining their relative sensitivity, concordance, and clinical implications ...
Carlos Casas‐Arozamena +15 more
wiley +1 more source
Poly-Cauchy numbers of the second kind - the combinatorics behind [PDF]
Be\'ata B'enyi, Jos\'e L. Ram\'ırez‡
doaj
On cohomology operations of the second kind.
openaire +3 more sources
A symbolic dataset for large language models to solve second kind Fredholm integral equations. [PDF]
Dana Mazraeh H +3 more
europepmc +1 more source
A urine‐based digital PCR assay targeting two hotspot TERT promoter variants detected bladder cancer with high sensitivity and no false positives in this case–control cohort. The streamlined AbsoluteQ workflow outperformed Sanger sequencing and supports non‐invasive molecular testing for bladder cancer detection.
Anna Nykel +12 more
wiley +1 more source
On Pillai's Problem involving Lucas sequences of the second kind. [PDF]
Heintze S, Ziegler V.
europepmc +1 more source
This study shows that lung adenocarcinomas exploit developmental branching morphogenesis to acquire a therapy resistant basal‐like tumour cell state. This process was found to be regulated by combined TP53 loss‐of‐function and type‐I interferon signalling, identifying a novel axis for biomarker and therapeutic target discovery.
Kamila J Bienkowska +13 more
wiley +1 more source
Combining osimertinib with the STING agonist ADU‐S100 activates innate and adaptive immunity to overcome the non‐inflamed microenvironment of Egfr‐mutant lung cancer. This combination increases NK and CD8+ T‐cell infiltration, associated with activation of the STING‐IRF3 pathway and local immunogenic cell death.
Jun Nishimura +19 more
wiley +1 more source

